Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals

Journal of Interferon and Cytokine Research

Volumn 34, Issue 5, 2014, Pages 385-393

  Lacerda, Heloísa Ramos ^a,b   Falcão, Maria Da Conceição Correia ^a   De Albuquerque, Valéria Maria Gonçalves ^a,b   Zírpoli, Josefina Claudia ^a   De Barros Miranda Filho, Demócrito ^b   De Albuquerque, Maria De Fátima Pessoa Militão ^c   Montarroyos, Ulisses ^a   De Alencar Ximenes, Ricardo Arraes ^a,b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELL ADHESION MOLECULE; CYTOKINE;

ADULT; AGE; ARTICLE; BLACK PERSON; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; EVALUATION STUDY; FAMILY HISTORY; FEMALE; FRAMINGHAM RISK SCORE; GENDER; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; PRIORITY JOURNAL; SKIN COLOR; SMOKING; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; CARDIOVASCULAR DISEASES; COMPLICATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; RISK FACTOR; VIROLOGY;

ADULT; ANTI-HIV AGENTS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84900338072     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0029     Document Type: Article

References (27)

1. Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, et al. 2012. HIV Status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis 55(1):126-136.
2. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard J, Wiman B, et al. 2006. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 187(2):408-414.
3. Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, French MA, et al. 2011. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 203(11):1637-1646.
4. Cheung BM, Ong KL, Tso AW, Leung RY, Xu A, Cherny SS, et al. 2012. C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort. J Hum Hypertens 26(2):108-116.
5. Chun TW, Fauci AS. 2012. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS (London, England) 26(10):1261-1268.
6. Cozzi-Lepri A, French MA, Baxter J, Okhuysen P, Plana M, Neuhaus J, et al. 2011. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. AIDS (London, England) 25(9):1207-1217.
7. Deeks SG. 2011. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 62:141-155.
8. Duvnjak L, Duvnjak M. 2009. The metabolic syndrome-an ongoing story. J Physiol Pharmacol 60 Suppl 7:19-24.
9. Eastburn A, Scherzer R, Zolopa AR, Benson C, Tracy R, Do T, et al. 2011. Association of low level viremia with inflammation and mortality in HIV-infected adults. PLoS One 6(11):e26320.
10. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. 2006. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med 355(22):2283-2296.
11. French MA, King MS, Tschampa JM, da Silva BA, Landay AL. 2009. Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4 + T cells. J Infect Dis 200(8):1212-1215.
12. Hunt PW. 2007. Role of immune activation in HIV pathogenesis. Curr HIV/AIDS Rep 4(1):42-47.
13. Kishimoto T. 2010. IL-6: from its discovery to clinical applications. Int Immunol 22(5):347-352.
14. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. 2009. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360(18): 1815-1826.
15. Kuller LH, Tracy R, BellosoW, DeWit S, Drummond F, Lane HC, et al. 2008. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5(10):e203.
16. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, et al. 2003. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 170(1):169-176.
17. Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA. 2011. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis 214(2):468-473.
18. Mochizuki K, Misaki Y, Miyauchi R, Takabe S, Shimada M, Miyoshi N, et al. 2011. Circulating interleukin-1beta and interleukin- 6 concentrations are closely associated with gammaglutamyltranspeptidase activity in middle-aged Japanese men without obvious cardiovascular diseases. Metabolism 60(7): 914-922.
19. Neuhaus J, Jacobs DR, Jr., Baker JV, Calmy A, Duprez D, La Rosa A, et al. 2010. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201(12):1788-1795.
20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, et al. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499-511.
21. Plaeger SF, Collins BS, Musib R, Deeks SG, Read S, Embry A. 2012. Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary. AIDS Res Hum Retroviruses 28(5):469-477.
22. Regidor DL, Detels R, Breen EC, Widney DP, Jacobson LP, Palella F, et al. 2011. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS (London, England) 25(3):303-314.
23. Scarpellini E, Tack J. 2012. Obesity and metabolic syndrome: an inflammatory condition. Dig Dis (Basel, Switzerland) 30(2): 148-153.
24. Singh T, Newman AB. 2011. Inflammatory markers in population studies of aging. Ageing Res Rev 10(3):319-329.
25. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, et al. 2009. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373(9672):1352-1363.
26. Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, et al. 2012. Endothelial cells, cholesterol, cytokines, and aging. Int J Immunopathol Pharmacol 25(2):355-363.
27. Zakynthinos E, Pappa N. 2009. Inflammatory biomarkers in coronary artery disease. J Cardiol 53(3):317-333.